EXCELLA Post-Approval Study
NCT02009956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2021-04-26
Summary
To evaluate long-term safety and performance of the DESyne Novolimus Eluting Coronary Stent System and the DESyne BD Novolimus Eluting Coronary Stent System
Conditions
Interventions
- DEVICE
-
Subjects receiving DESyne Novolimus Eluting CSS
Sponsors & Collaborators
-
Elixir Medical Corporation
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-26
- Primary Completion
- 2015-03-02
- Completion
- 2016-06-01
Countries
- Germany
- Jordan
- Spain
Study Locations
More Related Trials
-
EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease
NCT01310309 ·Status: COMPLETED
-
Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial
NCT02086045 ·Status: COMPLETED ·Phase: NA
-
A Pilot First In Man Study of EXCEL-Ⅱto Treat the Patients With de Novo Coronary Artery Lesions
NCT01909869 ·Status: COMPLETED ·Phase: NA
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
NCT00232856 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective, Multi-Center, Random. Study of CoStar Paclitaxel-Eluting Coronary Stent(Direct Stenting vs. Pre-Dilatation)
NCT00440674 ·Status: TERMINATED ·Phase: PHASE4
-
DESyne X2 Post Market Follow-up Study
NCT04375085 ·Status: TERMINATED ·Phase: NA
-
The SELUTION DeNovo Study
NCT04859985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions
NCT00825773 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
NCT00495898 ·Status: COMPLETED ·Phase: PHASE4
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED
-
Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES
NCT02367495 ·Status: COMPLETED ·Phase: NA
-
International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions
NCT01373502 ·Status: COMPLETED ·Phase: NA
-
EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)
NCT02027870 ·Status: COMPLETED
-
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
NCT00638794 ·Status: COMPLETED
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease
NCT01247428 ·Status: COMPLETED ·Phase: PHASE2
-
Elixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Registry
NCT04034121 ·Status: COMPLETED ·Phase: NA
-
The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries
NCT01025869 ·Status: TERMINATED ·Phase: NA
-
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
NCT00531011 ·Status: COMPLETED ·Phase: PHASE4
-
The Intra-Drug Eluting Stent (DES) Restenosis Study
NCT00323895 ·Status: COMPLETED ·Phase: PHASE4
-
The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.
NCT00232791 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
NCT01166685 ·Status: COMPLETED ·Phase: PHASE4
-
Medtronic RevElution Trial
NCT02480348 ·Status: COMPLETED ·Phase: NA
-
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
NCT04475380 ·Status: COMPLETED